Pathway Attenuation of Fatty Acid Beta-Oxidation in the Skeletal Muscle of a Type 2 Diabetic Mouse Model

Yang Zhou,Yifan Tan,Guixue Hou,Yan Ren,Yamei Deng,Keqiang Yan,Yue Zhang,Liang Lin,Xiaomin Lou,Siqi Liu

DOI: https://doi.org/10.1002/rcm.8869

IF: 2.586

2020-01-01

Rapid Communications in Mass Spectrometry

Abstract:Rationale Whether catabolic abnormalities of fatty acids exist in the skeletal muscle of type 2 diabetes mellitus (T2DM) has not been determined. In this study, we postulated that a systematic evaluation of the protein abundance and metabolic activity related to fatty acids in the skeletal muscle tissues of a T2DM mouse model was feasible to address this question. Methods Mitochondria were extracted from wild-type (WT) and db/db mice followed by quantitative analysis of the proteins involved in mitochondrial fatty acid oxidation (mFAO). The pathway activity of mFAO in skeletal muscle tissues was monitoredin vitrousing mass spectrometry, and tissue lipidomic analysis was conducted in profiling and target mode to distinguish the levels of long-chain acylcarnitines between WT and db/db mice. Results Two proteins related to the mFAO pathway were significantly downregulated in the skeletal muscle mitochondria of db/db mice. The measurement of mFAO pathway activityin vitrorevealed that the abundance of long-chain acylcarnitines (C14 to C18) in db/db mice was lower than that in WT mice, and the determination of acylcarnitines in skeletal muscle tissuesin vivorevealed that most long-chain acylcarnitines were decreased in db/db mice. Conclusions The findings of lower abundance of ACAD9 and CPT1B, reduced activity of the mFAO pathwayin vitroand decreased acylcarnitinesin vivofirmly support that the mFAO pathway in the skeletal muscle of diabetic mice is attenuated, possibly resulting in cell/tissue dysfunction in diabetes.